Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vidac Pharma logo — New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC...

Vidac Pharma

New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenvironment . Clinical Stage.

Founded 2011 Israel Israel 8 employees Series A Total: $9.00M Biopharma, Biotechnology +2

General Information

Company Name Vidac Pharma
Founded Year 2011
Location Israel Israel
Employees 8
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Vidac Pharma. To contact Vidac Pharma, visit vidacpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Vidac Pharma

Vidac Pharma is a clinical stage biopharmaceutical company founded in 2011. The company's slogan "New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenvironment" reflects its dedication to discovering and developing first-in-class medicines for oncology and dermatology ailments. Vidac is focused on leveraging breakthrough science to develop innovative therapies that address major unmet medical needs. The company's innovative technology targets the VDAC/HK2 system unique to malignant cells. This technology has the potential to selectively induce apoptosis in cancer cells without impacting healthy tissue, offering the promise of efficacious and well-tolerated first-in-class drugs. Vidac's last recorded investment was a $9.00M Series A investment on 29 June 2016, led by Israel Biotech Fund. With a focus on biopharma, biotechnology, health care, and pharmaceutical industries, Vidac Pharma is positioned to make significant strides in cancer drug discovery and treatment. The company's headquarters is located in Israel, positioning it within a vibrant and innovative biotech ecosystem.

Taxonomy: Clinical Stage, Cancer Drug Discovery, Oncology, Dermatology, Tumor Microenvironment, Skin Cancer, Apoptosis, HK2, VDAC, Malignant Cells, Biopharmaceutical, Innovative Therapies, Warburg Effect, Efficacious Drugs

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $9.00M 1
Israel Biotech Fund
Israel Biotech Fund
29 Jun 2016

Vidac Pharma Alternatives & Competitors

Vidac Pharma vs
Tarveda Therapeutics
Tarveda Therapeutics United States

To discover, develop and commercialize a new class of potent and selective precision oncology medici...

5 employees
Biotechnology, Health Care
Vidac Pharma vs
Laminar Pharma
Laminar Pharma Spain

Biopharmaceutical company performing discovery, rational design and initial clinical development of...

39 employees
Biotechnology, Life Sciences
Vidac Pharma vs
Sensei Bio
Sensei Bio United States

We follow the immune system’s teachings to discover new treatments that inspire the body to fight ca...

Series B
32 employees
Biotechnology, Health Care

FAQ About Vidac Pharma

New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenvironment . Clinical Stage.
Vidac Pharma was founded in 2011.
Vidac Pharma is headquartered in Israel.
Vidac Pharma operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Clinical Stage, Cancer Drug Discovery, Oncology and Dermatology.
Vidac Pharma has approximately 8 employees.
Vidac Pharma has completed 1 funding round, raising a total of $9.00M. The latest funding stage is Series A.
Top alternatives and competitors to Vidac Pharma include Tarveda Therapeutics, Laminar Pharma, Sensei Bio, Tetralogic Pharmaceuticals, AmpliMed Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vidac Pharma and Tarveda Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vidac Pharma, https://bouncewatch.com/company/vidac-pharma, updated 13 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes